Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.
Clinical trial NCT01559090 · COMPLETED
Trial details
- NCT number
- NCT01559090
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-20
- Primary completion
- 2014-08-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.